✦ LIBER ✦

Measurement of plasma von Willebrand factor in acute coronary syndromes and the influence of ABO blood group status

✍ Scribed by K. K. Ray; S. Francis; D. C. Crossman

Book ID: 109148590
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 104 KB
Volume: 2
Category: Article
ISSN: 1538-7933
DOI: 10.1111/j.1538-7836.2004.00965.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Association of ABO(H) and I blood group

Association of ABO(H) and I blood group system development with von Willebrand factor and Factor VIII plasma levels in children and adolescents

✍ Dieter Klarmann; Christine Eggert; Christof Geisen; Sabine Becker; Erhard Seifri 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 268 KB

Effect of ABO blood group on the collage

Effect of ABO blood group on the collagen-binding assay for von Willebrand factor

✍ Erin Haley; Nadiya Babar; Cory Ritter; Katharine A. Downes; Deana Green; Susan S 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 46 KB 👁 1 views

Risk of acute ischemic heart disease in

Risk of acute ischemic heart disease in postmenopausal women depends on von Willebrand factor and fibrinogen concentrations, and blood group genotype

✍ M. ROEST; H. A. M. VOORBIJ; A. D. BARENDRECHT; P. H. M. PEETERS; Y. T. VAN DER 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 501 KB

Treatment and prevention of acute bleedi

Treatment and prevention of acute bleedings in von Willebrand disease – efficacy and safety of Wilate®, a new generation von Willebrand factor/factor VIII concentrate

✍ E. BERNTORP; J. WINDYGA; THE EUROPEAN WILATE STUDY GROUP 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

Value assignment of the WHO 6th Internat

Value assignment of the WHO 6th International Standard for blood coagulation factor VIII and von Willebrand factor in plasma (07/316)

✍ A. R. HUBBARD; M. HAMILL; M. BEEHARRY; S. A. BEVAN; A. B. HEATH; on behalf of th 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

Treatment with tumor necrosis factor inh

Treatment with tumor necrosis factor inhibitors and the risk of acute coronary syndromes in early rheumatoid arthritis

✍ Lotta Ljung; Julia F. Simard; Lennart Jacobsson; Solbritt Rantapää-Dahlqvist; Jo 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB 👁 3 views

## Abstract ## Objective Rheumatoid arthritis (RA) is associated with an increased risk of ischemic heart disease, in both early and established RA. Data on the risk of ischemic heart disease in relation to therapy with tumor necrosis factor (TNF) antagonists (anti‐TNF) are conflicting in patients